title: [Prognostic factors in radiotherapy of supraglottic cancer].
abstract: In 971 patients with squamous cell carcinoma of supraglottic larynx several clinical and physical prognostic factors were evaluated. There were 55% of patients with advanced primary tumours and 71% of patients with no regional neck metastases. All patients were irradiated radically using external megavoltage beam. The total dose was in range 60-70 Gy for 95% of patients. The 3-year local control rate and 3-year overall in whole group were 41% and 50% respectively. Clinical stage, haemoglobin level at the end of treatment, overall treatment time, sex and total dose were estimated as an independent and important prognostic factors for the outcome in radiotherapy of supraglottic larynx cancer.
authors.affiliation: I Kliniki Radioterapii, Centrum Onkologii Instytutu im. Marii Skłodowskiej-Curie, Oddział w Gliwicach.
authors.forename: K
authors.initials: K
authors.lastname: Składowski
authors.forename: A
authors.initials: A
authors.lastname: Zajusz
authors.forename: J
authors.initials: J
authors.lastname: Swiatnicka
authors.forename: M
authors.initials: M
authors.lastname: Maciejewska
authors.forename: T
authors.initials: T
authors.lastname: Krupska
authors.forename: S
authors.initials: S
authors.lastname: Majewski
authors.forename: S
authors.initials: S
authors.lastname: Szelc
authors.forename: J
authors.initials: J
authors.lastname: Swiecki
authors.forename: B
authors.initials: B
authors.lastname: Maciejewski
mesh_terms: D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000532:radiotherapy*; D005260:Female; D005931:Glottis / Q000473:pathology* / Q000528:radiation effects*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D011446:Prospective Studies; D011829:Radiation Dosage